Get covered by the publications that won’t return your emails.
Digital PR built for cannabinoid brands — founder bylines in Forbes, expert quotes in Marie Claire, regulatory explainers in The Telegraph, and DR 70+ editorial links from journalists who actually understand CBD. No directory junk, no PBNs, no "guest post" inboxes.
Real journalists won't open a CBD pitch from someone they've never heard of.
Tier-1 publications spam-flag CBD outreach by default. Even when they bite, legal kills the link. Three years of being on first-name terms with the editors, lawyers and freelancers who actually publish cannabinoid stories — that's what we're selling.
- 01Cold CBD pitches go straight to spamNewsroom filters quietly junk CBD outreach. We pitch from warm relationships, not cold inboxes — and it shows in a 34% reply rate.
- 02Legal strips do-follow links from CBD coverageBig mastheads default to nofollow on CBD — or remove the link entirely. We know which titles allow do-follow and how to frame the story so legal signs off.
- 03Generic PR agencies treat you like a vape brandMost agencies have one "cannabis" template. We've spent five years inside the FDA, FSA, ASA and MHRA briefing notes the editors actually read.
Six PR engines. One newsroom-grade output.
Every Digital PR retainer ships these six outputs — per brand, per month, in a live clipbook.
Tier-1 stories — Forbes, Wired, Vogue, The Telegraph
The headline output: editorial features in DR 70+ mastheads. We pitch warm, frame for legal, and only count placements that ship with a do-follow link to your domain.
- Tier-1 mastheads only (DR 70+)
- Do-follow links contractually warranted
- Story angle approved before pitching
Bylined op-eds that turn your founder into the expert
Ghost-written, founder-edited op-eds and explainers in tier-1 wellness, business and cannabis press. Each byline lands a do-follow author bio and a topic the founder can talk about for the next year.
- Topic, outline & first draft handled
- Founder edits before publish
- Author bio + brand do-follow on every piece
Get quoted in stories already being written
We monitor Connectively (HARO), Qwoted, ResponseSource and 14 private journalist Slacks for CBD queries — and pitch your founder as the expert. 34% of our pitches turn into a published quote.
- Daily monitoring · 14 journalist channels
- Pitch drafted within 90 minutes of brief
- 34% pitch-to-publication win rate
Be the source on every CBD news cycle
FSA approval lists. New FDA guidance. A celebrity launches a hemp brand. We brief your founder within 2 hours and pitch a quote, op-ed or feature angle to the journalists already covering it.
- 2-hour news-to-pitch SLA
- Pre-approved talk-track per regulator beat
- Live trend dashboard inside your workspace
Wire-grade announcements that journalists actually pick up
Funding rounds, FDA letters, lab certifications, distribution deals — written to AP style, distributed to a CBD-friendly journalist list of 1,840 contacts, syndicated on PR Newswire, Business Wire and 12 niche cannabinoid wires.
- AP-style writeup & embargo coordination
- 1,840 cannabinoid-friendly journalist list
- PR Newswire + Business Wire syndication
Every brand mention — tracked, linked, recovered
We monitor 200+ CBD-relevant outlets for unlinked mentions of your brand and convert them into do-follow links within 7 days. The dashboard shows link-velocity week-over-week, plotted against competitors.
- 200+ outlets monitored daily
- Unlinked mention → do-follow conversion (7-day SLA)
- Competitor link-velocity benchmarks
Your PR newsroom, live.
Editorial pipeline, journalist DMs, link velocity, and clipbook — refreshed every six hours.
Top placements · live now
Output share
Compliance flags
Full clipbook · OriginalsCBD · last 90 days
Pipeline · in flight
Warm journalist relationships · CBD beat
Link velocity · last 12 weeks · do-follow only
Six weeks to first tier-1 placement. Then we compound.
Every Digital PR engagement opens with a forensic narrative audit, then locks into a monthly compounding sprint.
- 01Week 1 · AuditNarrative + journalist-relationship auditMap your current coverage. Score do-follow density. Identify the 5 angles only your founder can credibly own.
- 02Week 2 · Story-bankBuild a 12-month story bank12 angles, each tied to a regulator beat or research moment. Pre-cleared with founder + legal so we can move at news speed.
- 03Weeks 3–4 · PitchWarm-pitch tier-1 mastheadsFirst wave: 12 pitches into our warm CBD-beat journalist list. Founder bylines drafted in parallel.
- 04Weeks 5–6 · First waveFirst DR 70+ placements liveEditorial features + founder byline + first 4 expert quotes ship. Clipbook live in your dashboard.
- 05Month 2+ · CompoundReactive newsjacking + HARO compoundingDaily journalist monitoring, 2-hour newsjack SLA, weekly clipbook review on Slack.
- 06QuarterlyFounder review + narrative refresh90-day deep dive. Refresh story bank. Renew, expand or part ways — you choose.
Real CBD brands. Real tier-1 clipbooks.
Three case studies from the last 12 months — numbers pulled straight from each brand's clipbook.
From zero to 9 tier-1 placements in 90 days
Avg DR 88.4. Founder bylines in Forbes & The Telegraph. Expert quotes in Marie Claire, Bustle, Yahoo Finance. Link velocity 10× baseline.
+184% organic traffic from 24 tier-1 links
24 DR 70+ placements across Vogue, Wired, Yahoo and High Times in 6 months. Branded search up 312%. M&A inquiries from three Fortune 500s within Q2.
Avg DR 78 across 14 placements in 4 months
Reactive newsjacking on the FSA full-spectrum approval cycle — 9 placements within the same 14-day news window. Telegraph + Independent + Times in one quarter.
Six reasons CBD founders trust us with their newsroom relationships.
189 warm CBD-beat journalists
A CRM of 189 journalists, editors and freelancers we've placed CBD stories with — on first-name terms with the desks at Forbes, Wired, Vogue and The Telegraph.
DR 70+ tier-1 placements only
We don't count guest posts on DR 28 wellness blogs. Every placement we report is DR 70+ and contractually do-follow.
34% HARO win-rate
Industry average for journalist-pitch reply is 4%. Ours is 34% — because we pitch from warm relationships, not blast lists.
2-hour newsjack SLA
News breaks, your founder's quote is drafted within two hours. Reactive PR is where DR 90+ placements actually live.
5+ years cannabinoid-only
We've been pitching CBD stories since 2019. We know which legal teams strip do-follow links and how to frame so they don't.
90-day tier-1 warranty
DR 70+ placement in 90 days, or the next month is on us. Written into every contract.
"They got us into the rooms our last agency couldn't even email."
Three PR agencies told us Forbes wouldn't touch CBD. CBDSEOXperts placed our founder byline in Forbes Health within 60 days — and three more tier-1s by Q2.
The reactive newsjacking is the unlock. FSA dropped a press release at 9am, our quote was in The Telegraph by 4pm. That doesn't happen with normal PR.
We tried generic PR for two years and got DR 35 wellness blogs. One quarter with CBDSEOXperts and our clipbook had The Times, Independent and Telegraph in it.
Three tiers. Founder-led on every retainer. Tier-1 warranty included.
For early-stage CBD brands ready to land their first tier-1 placements.
- ✓2 editorial placements / month (DR 70+)
- ✓1 founder byline / quarter
- ✓Daily HARO + Connectively monitoring
- ✓Live clipbook dashboard + Slack channel
- ✓90-day DR 70+ warranty
For CBD brands competing for category leadership across UK + US press.
- ✓4 editorial placements / month (DR 70+)
- ✓2 founder bylines / month
- ✓Reactive newsjacking (2-hour SLA)
- ✓1 wire-grade press release / quarter
- ✓Quarterly founder review
For CBD brands at scale — multi-market, multi-spokesperson, with ongoing news cadence.
- ✓8 editorial placements / month (DR 70+)
- ✓Unlimited founder bylines + expert quotes
- ✓Dedicated senior strategist + writer
- ✓Monthly wire releases + crisis comms desk
- ✓Monthly founder review
The questions CBD founders actually ask before signing.
Don't see yours? Reply to any audit email — founder answers within 24 hours.
Do you actually get CBD brands into Forbes, Wired and Vogue, or is "tier-1" just marketing language?
What's the catch with do-follow links from tier-1 publications?
How is this different from generic digital PR?
What if my brand isn't FDA-compliant or has a regulatory issue?
How fast can I expect first placements?
Do I keep ownership of journalist relationships if I leave?
What happens if a publication strips the link or kills the mention after publish?
See exactly which tier-1s your CBD brand can realistically land in 90 days.
Drop your domain. We'll audit your existing coverage, score do-follow density, and email back the 5 angles only your founder can credibly own. 48-hour turnaround. No credit card.
[wpforms id="123"] or [gravityform id="1" ajax="true"]).Average audit turnaround: 36 hours · 100+ CBD brands served